Posted in | News | Materials Processing

UOP and Albemarle Form Hydroprocessing Alliance

UOP LLC, a Honeywell company, and Albemarle Corporation have announced that they have entered into an agreement to form a hydroprocessing alliance to help the petroleum refining industry produce clean fuels.

The alliance, in which Albemarle's joint venture Nippon Ketjen will participate as well, will offer a wide range of hydroprocessing technologies, catalysts and services to assist refiners in meeting the projected increased demand for refined products and ultra-low-sulfur fuels. Hydroprocessing technologies and catalysts are used in virtually all petroleum refineries around the world and are essential for the production of clean fuels.

The alliance builds on the complementary strengths of UOP, a leading hydroprocessing technology and catalyst supplier, and Albemarle, a leading supplier of refinery hydrotreating catalysts and technologies. The alliance will specifically provide customers a broad portfolio of process and catalyst offerings for middle distillate hydrotreating, vacuum gas oil hydrotreating, mild hydrocracking, hydrocracking, and fixed-bed residue hydrotreating.

"We are very excited to enter into this strategic alliance with UOP," said Mark Rohr, Albemarle president and CEO. "Our two organizations have a long history of working together to the benefit of our hydroprocessing customers and stakeholders."

"The future of the refining industry will be characterized by a substantial increase in crude and hydroprocessing capacity to meet the growing demand for clean fuels," added UOP president and CEO Carlos A. Cabrera. "The alliance's suite of leading hydroprocessing technologies and catalysts will play a key role in meeting these requirements."

http://www.albemarle.com/

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.